Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism

Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism

Antipsychotic drugs (APs) have profoundly changed the treatment landscape for psychiatric disorders, yet their impact on neuroplasticity and neurotrophism remains only partially understood. While second-generation antipsychotics (SGAs) are associated with a better side effect profile than their pred...

Full description

Saved in:
Bibliographic Details
Main Authors: Federico Mucci, Alessandro Arone, Riccardo Gurrieri, Francesco Weiss, Gerardo Russomanno, Donatella Marazziti
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Life
Subjects:
neuroplasticity
neurotrophism
third-generation antipsychotics
brexpiprazole
cariprazine
lurasidone
Online Access:https://www.mdpi.com/2075-1729/15/3/391
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items